Inovio Pharmaceuticals Inc (INO)

[steadyhand]

If anyone here can read a chart... its obv you should buy, let alone the facts. And here are the facts: the market and biological challenges of vaccine development, short-term use (roughly 0 cases of MERS or SARS these days), would make this stock not all that attractive. And hence you see a few "tisk tisk" high brow folks saying well this is not an immunotherapy or RA drug with a huge and lasting market cap. BUT... this is going to be driven up by lay people's concern and a test of how advanced and fast a company can deploy a vaccine. It is a "space race" of shorts. Not a great long term plan (we knew the moon was just dirt and rocks) but this is about pushing boundaries in a globalized world. Buckle up and buy folks. Corna is spreading fast and this company is wanting to do something about it. People's demand for a vaccine, not true pharma market realities are at work here.